Wu, N., Zhang, J., Zhao, J., Mu, K., Zhang, J., Jin, Z., . . . Liu, J. (2018). Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer. Oncol Lett.
Chicago Style CitationWu, Nan, Jinghua Zhang, Jing Zhao, Kun Mu, Jun Zhang, Zhao Jin, Jinpu Yu, i Juntian Liu. "Precision Medicine Based On Tumorigenic Signaling Pathways for Triple-negative Breast Cancer." Oncol Lett 2018.
Cita MLAWu, Nan, et al. "Precision Medicine Based On Tumorigenic Signaling Pathways for Triple-negative Breast Cancer." Oncol Lett 2018.
Atenció: Aquestes cites poden no estar 100% correctes.